Trial intelligence / Profile preview

TF effects on blood lipids in hyperlipidaemia

IRCT2013111815452N1Phase 2Completed

Sponsor
Qazvin University of Medical Sciences
Start
Jan 2014
Modality
Peptides
Countries
1
01

Overview

Phase 2 trial of Transferon in hyperlipidemia, sponsored by Qazvin University of Medical Sciences. Primary endpoint: Change in blood lipid levels. Started Jan 2014; status: completed.

02

Drugs

Transferon
03

Conditions

hyperlipidemia

Beyond the preview

Go deeper on IRCT2013111815452N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013111815452N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call